Dolutegravir plus lamivudine shows comparable efficacy and safety with standard-of-care three-drug regimen in patients with ...

People who can't afford the name-brand drugs have been flocking to compounded versions, which are available at a fraction of ...

Immunovant said on Wednesday its experimental treatment for a type of chronic muscle weakness improved patients' symptoms and that it aimed to use the data to accelerate the development of a newer ...

The FDA granted orphan drug designation to HLX22 for gastric cancer, advancing global phase 3 trials to improve first-line ...

The convergence of AI and drug delivery is opening new frontiers in precision medicine. AI-powered predictive modeling is ...

But now scientists are touting the efficacy of a new drug that can stop COVID before it even starts if you've been exposed.

The explosion of GLP-1 weight loss drugs is reminiscent of the early days of PD-1 inhibitors, but key market differences ...

Data from two studies suggest that a once-daily combination therapy of doravirine and islatravir was noninferior to current, ...

Mycobacterium abscessus is a fast-growing, pathogenic mycobacteria that can cause lung infections, and people who have ...

The field of cancer treatment has long struggled with the immense costs and time-consuming nature of drug development.

New active ingredients such as antibodies are usually tested individually in laboratory animals. Researchers at UZH have now ...